Clinical Trial Update: Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of therapeutic anticoagulation in hospitalized COVID-19 patients; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Cardiovascular Diseases, COVID-19 | Phase 2 | Status: UNKNOWN